4.7247
                                            Schlusskurs vom Vortag:
              $4.78
            Offen:
              $4.68
            24-Stunden-Volumen:
                744.91K
            Relative Volume:
              0.73
            Marktkapitalisierung:
                $242.29M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-54.19M
            KGV:
              -1.8313
            EPS:
                -2.58
            Netto-Cashflow:
                $-37.34M
            1W Leistung:
              -10.38%
            1M Leistung:
              -12.53%
            6M Leistung:
                -27.86%
            1J Leistung:
              -21.65%
            Abeona Therapeutics Inc Stock (ABEO) Company Profile
Firmenname
                  
                      Abeona Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      646-813-4701
                    
                Adresse
                  
                      6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
                    
                Vergleichen Sie ABEO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ABEO
                            
                             
                        Abeona Therapeutics Inc 
                           | 
                    4.725 | 245.11M | 0 | -54.19M | -37.34M | -2.58 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.52 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    635.93 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    427.26 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    841.69 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    184.96 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform | 
| 2025-03-05 | Eingeleitet | Oppenheimer | Outperform | 
| 2024-07-03 | Eingeleitet | H.C. Wainwright | Buy | 
| 2024-05-30 | Eingeleitet | Stifel | Buy | 
| 2020-11-11 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight | 
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy | 
| 2020-02-10 | Eingeleitet | SVB Leerink | Outperform | 
| 2019-12-10 | Fortgesetzt | Cantor Fitzgerald | Neutral | 
| 2019-08-15 | Herabstufung | Maxim Group | Buy → Hold | 
| 2019-08-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral | 
| 2019-07-26 | Herabstufung | Mizuho | Buy → Neutral | 
| 2019-06-27 | Eingeleitet | Mizuho | Buy | 
| 2018-10-12 | Eingeleitet | Mizuho | Buy | 
| 2018-06-05 | Eingeleitet | Seaport Global Securities | Buy | 
| 2017-11-08 | Eingeleitet | SunTrust | Buy | 
| 2017-10-16 | Bestätigt | H.C. Wainwright | Buy | 
| 2017-10-11 | Bestätigt | Cantor Fitzgerald | Overweight | 
| 2017-10-10 | Eingeleitet | Citigroup | Buy | 
| 2017-10-05 | Bestätigt | Maxim Group | Buy | 
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform | 
| 2017-07-18 | Bestätigt | Maxim Group | Buy | 
| 2017-06-22 | Fortgesetzt | Jefferies | Buy | 
| 2017-01-06 | Eingeleitet | Jefferies | Buy | 
| 2016-09-29 | Bestätigt | Maxim Group | Buy | 
                    Alle ansehen
                    
                  
                Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
Is Abeona Therapeutics Inc. (PCJ) stock a top dividend aristocrat candidateJuly 2025 Outlook & AI Optimized Trade Strategies - newser.com
How Abeona Therapeutics Inc. stock reacts to inflationary pressuresBull Run & Daily Stock Momentum Reports - newser.com
Can Abeona Therapeutics Inc. stock sustain institutional interestWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
How Abeona Therapeutics Inc. stock reacts to job market dataCPI Data & Low Volatility Stock Recommendations - newser.com
What downside risks could hit Abeona Therapeutics Inc. (PCJ) stockJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - newser.com
Why retail investors favor Abeona Therapeutics Inc. stockQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Abeona Therapeutics (ABEO) Grants Equity Awards to New Employees - GuruFocus
Sector ETF performance correlation with Abeona Therapeutics Inc.Weekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Abeona Therapeutics (NASDAQ: ABEO) grants 71,035 restricted shares to 11 new employees - Stock Titan
Will Abeona Therapeutics Inc. stock benefit from green energy trendsRisk Management & Precise Buy Zone Tips - newser.com
Visualizing Abeona Therapeutics Inc. stock with heatmapsJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com
Sentiment analysis tools applied to Abeona Therapeutics Inc.July 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
Can Abeona Therapeutics Inc. (PCJ) stock survive global slowdownMarket Risk Summary & Capital Protection Trade Alerts - newser.com
Should I hold or sell Abeona Therapeutics Inc. stock in 2025Trade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Abeona Therapeutics Inc. (PCJ) stock supported by free cash flow2025 Stock Rankings & Safe Entry Trade Reports - newser.com
Is Abeona Therapeutics Inc. stock oversold or undervaluedWeekly Stock Recap & Weekly Setup with ROI Potential - newser.com
Applying big data sentiment scoring on Abeona Therapeutics Inc.July 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com
Will Abeona Therapeutics Inc. (PCJ) stock benefit from Fed rate cutsBear Alert & AI Powered Buy and Sell Recommendations - newser.com
How dovish Fed policy supports Abeona Therapeutics Inc. (PCJ) stockPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
CMS assigns permanent J-code for Abeona’s RDEB therapy ZEVASKYN By Investing.com - Investing.com Australia
Is Abeona Therapeutics Inc. stock positioned for long term growthQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-31 02:43:41 - newser.com
Why Abeona Therapeutics Inc. (PCJ) stock could outperform next yearWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Abeona Therapeutics Inc. (ABEO) stock price, news, quote and history - Yahoo! Finance UK
Abeona Therapeutics Inc. (PCJ.F) stock price, news, quote and history - Yahoo! Finance Singapore
Abeona Therapeutics Gets Permanent CMS J-Code for Zevaskyn Gene Therapy - MarketScreener
Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):